ArticlePatient preference and adherence2020

Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis.

Jagadeswara R Earla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.